Clinical Investigator
Hong Wu, M.D., Ph.D.
West China Hospital
Total Trials
1
As PI
0
Completed
0
h-index
N/A
Publications
0
Years Active
0
Research Impact
h-index
N/A
Research impact score
Publications
0
Total publications
Trial Results
0
Published trial results
Citations
0
Total citations
Drug Portfolio
PROCEDURE(2)
DRUG(1)
Liver Venous Deprivation (LVD)
1 trial
not_applicable
hong-wuConventional Transarterial Chemoembolization(C-TACE)
1 trial
not_applicable
hong-wuTislelizumab combined with Lenvatinib
1 trial
not_applicable
hong-wu3 unique interventions2 categories
Analytics
Trial Phases
No phase data
Trial Status
Other1
Role Distribution
Other Roles1
Activity Timeline
Clinical Trials (1)
Safety and Efficacy of LVD + C-TACE + Tis/Len for Unresectable Right-Liver HCC
Initially Unresectable Hepatocellular Carcinoma
Studychair
Research Network
Collaboration Network
1 collaborators·0 connections
Network Legend
KOL
Current InvestigatorCO
High-influence CollaboratorCO
CollaboratorClick: view details
Double-click: go to profile
Drag: move node
Research Areas & Affiliations
Therapeutic Areas
Affiliations
West China Hospital
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Similar investigators will appear here based on research areas and collaboration patterns.
Publications (0)
No publications found for this investigator.
Clinical Trials (1)
Showing 1 of 1 trials
Safety and Efficacy of LVD + C-TACE + Tis/Len for Unresectable Right-Liver HCC
Initially Unresectable Hepatocellular Carcinoma
All 1 trials loaded